LifeMD will announce its financial results on March 9, 2026, with a conference call at 4:30 p.m. Eastern time.
Quiver AI Summary
LifeMD, Inc., a prominent provider of virtual primary care services, announced that it will release its financial results for the fiscal year and quarter ending December 31, 2025, on March 9, 2026, after U.S. markets close. Following the release, the company will hold a conference call at 4:30 p.m. Eastern time to discuss the results. LifeMD offers a variety of healthcare services through its digital platform, including telemedicine and specialized treatments, aiming to provide accessible and affordable care across more than 200 conditions. For further information, investors and media contacts are listed in the release.
Potential Positives
- LifeMD is set to report financial results for the year ended December 31, 2025, indicating transparency and ongoing communication with stakeholders.
- The scheduled conference call provides an opportunity for investors and analysts to gain insights directly from the company’s executives, enhancing investor relations.
- LifeMD emphasizes its role as a leading provider of virtual primary care, highlighting its comprehensive service offerings and commitment to accessible healthcare.
- The mention of a proprietary digital care platform and a strong medical support network suggests that LifeMD is well-positioned to capitalize on the growing telemedicine market.
Potential Negatives
- Announcement of upcoming financial results may highlight potential issues if they are not favorable, drawing investor concern over the company's performance.
- Hosting a conference call could indicate the need for transparency in response to past financial struggles, which might suggest previous difficulties.
- Failure to provide any preliminary insights into financial performance ahead of the results may create uncertainty and anxiety among investors.
FAQ
When will LifeMD report its financial results?
LifeMD will report its financial results on March 9, 2026, after the U.S. financial markets close.
What time is the LifeMD conference call?
The conference call is scheduled for 4:30 p.m. Eastern time on March 9, 2026.
How can I join the LifeMD conference call?
You can join by calling the toll-free number 800-343-5172 or the international dial-in at 203-518-9856.
What services does LifeMD provide?
LifeMD provides virtual primary care, telemedicine, laboratory access, and treatment for over 200 conditions.
Who should I contact for investor or media inquiries about LifeMD?
For investor inquiries, contact Marc Benathen at [email protected]. For media inquiries, contact Jessica Friedeman at [email protected].
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LFMD Insider Trading Activity
$LFMD insiders have traded $LFMD stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $LFMD stock by insiders over the last 6 months:
- NICHOLAS P ALVAREZ (Chief Acquisition Officer) sold 75,000 shares for an estimated $443,760
- JESSICA FRIEDEMAN (Chief Marketing Officer) sold 15,000 shares for an estimated $54,157
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LFMD Revenue
$LFMD had revenues of $60.2M in Q3 2025. This is an increase of 12.95% from the same period in the prior year.
You can track LFMD financials on Quiver Quantitative's LFMD stock page.
$LFMD Hedge Fund Activity
We have seen 51 institutional investors add shares of $LFMD stock to their portfolio, and 95 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NUVEEN, LLC removed 1,224,091 shares (-92.5%) from their portfolio in Q4 2025, for an estimated $4,174,150
- CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. removed 925,685 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,285,401
- FEDERATED HERMES, INC. added 721,018 shares (+278.1%) to their portfolio in Q4 2025, for an estimated $2,458,671
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. added 687,328 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,343,788
- MORGAN STANLEY removed 649,552 shares (-66.6%) from their portfolio in Q4 2025, for an estimated $2,214,972
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 434,937 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,953,222
- POINT72 ASSET MANAGEMENT, L.P. added 399,094 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,360,910
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LFMD Analyst Ratings
Wall Street analysts have issued reports on $LFMD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/19/2025
- Keybanc issued a "Overweight" rating on 11/19/2025
- Lake Street issued a "Buy" rating on 11/18/2025
- B. Riley Securities issued a "Buy" rating on 11/18/2025
- BTIG issued a "Buy" rating on 11/18/2025
To track analyst ratings and price targets for $LFMD, check out Quiver Quantitative's $LFMD forecast page.
$LFMD Price Targets
Multiple analysts have issued price targets for $LFMD recently. We have seen 6 analysts offer price targets for $LFMD in the last 6 months, with a median target of $8.5.
Here are some recent targets:
- Steve Dechert from Keybanc set a target price of $8.0 on 11/19/2025
- Steven Valiquette from Mizuho set a target price of $6.0 on 11/19/2025
- Yi Chen from HC Wainwright & Co. set a target price of $9.0 on 11/19/2025
- David Larsen from BTIG set a target price of $10.0 on 11/18/2025
- Brooks O'Neil from Lake Street set a target price of $8.0 on 11/18/2025
- William Woods from B. Riley Securities set a target price of $10.0 on 11/18/2025
Full Release
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.
Conference Call & Webcast Details
| Date: | Monday, March 9 th |
| Time: | 4:30 p.m. Eastern time |
| Toll-Free Dial-In: | 800-343-5172 |
| International Dial-In: | 203-518-9856 |
| Conference ID: | LIFEMD |
| Live & Archived Webcast: | Link |
About LifeMD, Inc.
LifeMD ® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com .
Investor Contact
Marc Benathen, Chief Financial Officer
[email protected]
Media Contact
Jessica Friedeman, Chief Marketing and Product Officer
[email protected]
